Tess Korthout, PhD, Business Development Manager, iClusion
Tess obtained a PhD at The Netherlands Cancer Institute, followed by a Postdoc at the Hubrecht institute. During this time, her research focussed on single-cell sequencing to discover epigenetic mechanisms driving cancer. This innovative project fuelled her passion for novel technologies and the biotech industry. Therefore, she joined the start-up environment at iClusion to help both small biotech as well as large pharmaceutical companies with innovating their clinical trials and accelerate patient recruitment.